CTYPE html> ProCanBio | Biomarker Card

Biomarker Card

This biomarker card gives comprehensive information about each biomarker.
Detailed Information
Biomarker ID860
PMID22302227
Year2012
BiomarkerInterleukin 8 (IL-8)
Biomarker BasisExpression Based
BiomoleculeProtein
SourcePlasma
SubjectsHumans
RegulationUpregulated in Treatment Group (Treatment: 5.7 (3.8–7.7) Vs Control : 2.2 (1.6–2.8) )
Odds Ratio/Hazard Ratio/Relative RiskNA
Effect on PathwaysNA
ExperimentADT Treatment Vs No Treatment
Type of BiomarkerPredictive
Cohort37 ADT-naïve men with locally advanced or recurrent prostate cancer. Of those, 23 initiated ADT with a gonadotropin-releasing hormone (GnRH) agonist and 14 served as nontreatment controls.
SenstivityNA
SpecificityNA
AUCNA
AccuracyNA
Level Of Significancep=0.0001
Method UsedELISA
ClinicalNo
RemarksNA
Clinical Trial NumberNA
Degree Of ValidityNot validated on independent patient dataset
Technical NameIL8